Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.

@article{Chisholm2005CosteffectivenessOF,
  title={Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.},
  author={Daniel Chisholm},
  journal={Epilepsia},
  year={2005},
  volume={46 5},
  pages={751-9}
}
PURPOSE To establish the population-level costs and cost-effectiveness of first-line antiepileptic drug (AED) treatments for reducing the treatment gap in developing countries. METHODS A population model was applied to nine World Health Organization (WHO) developing subregions to estimate the impact of four first-line AEDs in the primary care management of (ICD-10 defined) idiopathic epilepsy and epileptic syndromes: phenobarbitone (PB), phenytoin (PHT), carbamazepine (CBZ), and valproic acid… CONTINUE READING